首页> 美国卫生研究院文献>Integrative Cancer Therapies >The Usage of Curcumin as Chemopreventive Agent for Oral Squamous Cell Carcinoma: An Experimental Study on Sprague-Dawley Rat
【2h】

The Usage of Curcumin as Chemopreventive Agent for Oral Squamous Cell Carcinoma: An Experimental Study on Sprague-Dawley Rat

机译:姜黄素作为口腔鳞状细胞癌化学预防剂的用途:Sprague-Dawley大鼠的实验研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Curcumin, a natural herb that can be isolated from turmeric has been known for its therapeutic potential, including its chemopreventive potential, while heme oxygenase-1 (HO-1) is an antioxidant enzyme that can act as the biomarker for the progression of oral squamous cell carcinoma (OSCC). The current study investigated the efficacy of curcumin as a chemopreventive agent for OSCC by evaluating the immunoexpression of HO-1 at epithelial dysplasia stage. >Methods: The current experimental study was conducted at the Veterinary Medicine Faculty, Bogor Agricultural Institute, Indonesia, using 40 Sprague-Dawley rats. All rats were randomly divided into 1 of 2 groups: the experimental group that was fed with standard rat food and curcumin and the control group that was fed with standard rat food without curcumin. At the beginning of the fifth week, every animal was wounded on the right buccal mucosa and was exposed to 0.5% 7,12-dymethylbenz(a)anthracene 3 times a week for 4 weeks in order to induce epithelial dysplasia of OSCC. On the ninth week, the right buccal mucosa was biopsied and the immunoexpression of HO-1 in both groups was compared and analyzed. >Results: Sample examination revealed that all rats showed moderate to severe dysplastic epithelial dysplasia stage of OSCC, while a Mann-Whitney test showed that there was no significant (P = .09) difference found between the 2 groups for the immunoexpression of HO-1. >Conclusion: With regard to its chemopreventive potential, the curcumin dose used in the study was not proven to be effective. Further study is of importance.
机译:>背景:姜黄素是一种可以从姜黄中分离得到的天然草药,具有治疗潜力,包括其化学预防潜力,而血红素加氧酶-1(HO-1)是一种抗氧化酶,可以发挥作用作为口腔鳞状细胞癌(OSCC)进展的生物标志物。当前的研究通过评估上皮不典型增生阶段HO-1的免疫表达来研究姜黄素作为OSCC化学预防剂的功效。 >方法:目前的实验研究是在印度尼西亚茂物农业研究所兽医学院进行的,使用了40只Sprague-Dawley大鼠。将所有大鼠随机分为2组中的1组:实验组饲喂标准大鼠食物和姜黄素,对照组饲喂标准大鼠食物而不使用姜黄素。在第五周开始时,每只动物在右颊粘膜上受伤,并每周3次暴露于0.5%的7,12-二甲基苯并(a)蒽,持续4周,以诱导OSCC的上皮发育异常。在第九周,对右颊粘膜进行活检,并比较和分析两组中HO-1的免疫表达。 >结果:样本检查显示,所有大鼠均显示出中度至重度OSCC上皮增生异常增生期,而Mann-Whitney试验显示,两组之间无显着差异(P = .09)用于HO-1的免疫表达。 >结论:就其化学预防潜力而言,该研究中使用的姜黄素剂量尚未证明是有效的。进一步研究很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号